PMA device
Axium Neurostimulator System
Abbott Medical · Dorsal Root Ganglion Stimulator For Pain Relief (PMP, Class III) · First FDA decision Feb 11, 2016, newest Oct 8, 2024Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
20
Naming "Axium"
MAUDE reports
3,682
Brand "Axium", since 2015
PubMed studies
76
Mentioning "Axium"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Axium Neurostimulator System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 9 decisions filed under this name.
- Axium Neurostimulator SystemPMA supplement
P150004-S069 · Decided Oct 8, 2024 · 229 days after receipt · Normal 180 Day Track No User Fee
Device type: Dorsal root ganglion stimulator for pain relief (PMP) · Neurology & Neurosurgery
- Axium Neurostimulator SystemPMA supplement
P150004-S051 · Decided Aug 5, 2021 · 29 days after receipt · Normal 180 Day Track No User Fee
Device type: Dorsal root ganglion stimulator for pain relief (PMP) · Neurology & Neurosurgery
- Axium Neurostimulator SystemPMA supplement
P150004-S040 · Decided Jan 21, 2021 · 234 days after receipt · Normal 180 Day Track No User Fee
Device type: Dorsal root ganglion stimulator for pain relief (PMP) · Neurology & Neurosurgery
3 more FDA decisions with a free account
Older decisions: P150004-S005, P150004-S001, P150004
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Axium", any status and sponsor, newest update first.
- A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment for Chronic PainCompleted
Abbott Medical DevicesPublic (ABT)
NCT02169401 · 135 participants · Start Nov 2012 · Primary completion Jan 25, 2017
Device: Implantation with the commercially available Axium Neurostimulator · For: Chronic Pain
Sites: Middlesbrough, United Kingdom
- TARGET Post-Approval StudyCompleted
Abbott Medical DevicesPublic (ABT)
NCT02800863 · 426 participants · Start Aug 23, 2016 · Primary completion Sep 23, 2021
Device: Dorsal Root Ganglion (DRG) Stimulation (Axium™ Neurostimulator System); Dorsal Root Ganglion (DRG) Stimulation (Proclaim™ Neurostimulator System) · For: Complex Regional Pain Syndrome (CRPS)
Sites: Scottsdale, Arizona; Camarillo, California; Larkspur, California · 44 sites in all
The Cleveland ClinicAcademic, hospital or other
NCT03794024 · 1 participants · Start Jan 8, 2019 · Primary completion Mar 3, 2020
Device: The Nuvectra Algovita Dorsal Column Spinal Cord Stimulator; The Axium Neurostimulator System · For: Complex Regional Pain Syndrome
Sites: Cleveland, Ohio
17 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Axium", and for the whole product code for context.
This brand
3,682 reports: 2,876 malfunction, 730 injury, 75 death
Whole product code PMP
20,258 reports: 250 malfunction, 19,968 injury, 32 death
Newest reports for this brand
- AXIUM 3DMalfunction
Medtronic Mexico S. De R.L. De CV
9617601-2026-06582 · Received Oct 30, 2026 · Event dated Jul 20, 2026
Device type: Device, Vascular, For Promoting Embolization (KRD)
Device problem as coded: Stretched; Physical Resistance/Sticking
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- AXIUM PRIME BRPL HLXMalfunction
Medtronic Mexico S. De R.L. De CV
9617601-2026-06560 · Received Oct 29, 2026 · Event dated Jul 14, 2026
Device type: Device, Vascular, For Promoting Embolization (KRD)
Device problem as coded: Physical Resistance/Sticking
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- AXIUM PRIME BRPL 3DMalfunction
Medtronic Mexico S. De R.L. De CV
9617601-2026-06561 · Received Oct 29, 2026 · Event dated Jul 13, 2026
Device type: Device, Vascular, For Promoting Embolization (KRD)
Device problem as coded: Material Deformation; Physical Resistance/Sticking
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Axium"[tiab]. The summary above synthesizes these.
- Gekko Coil System for Intracranial Aneurysms Treatment in China (GREAT-China): A Prospective Randomized Controlled Open-Label Noninferiority Trial.
Duan G, Zhang Y, Li Q, et al. · World Neurosurg · 2024Multicenter Study, Randomized Controlled Trial
- Avenir® vs. AxiumTM Coils for the Treatment of Intracranial Aneurysms: Results of a Multicenter Randomized Controlled Trial With Short-Term Follow-Up.
Li W, Ye M, Cimpoca A, et al. · Front Neurol · 2021
- Randomized, prospective, multicenter trial assessing the numen coil embolization system in the endovascular treatment of small intracranial aneurysms: outcomes from the CATCH Trial.
Jin Y, Guo X, Quan T, et al. · BMC Surg · 2023Randomized Controlled Trial, Multicenter Study
- Prevalence of hyperdontia, hypodontia, and concomitant hypo-hyperdontia.
Eshgian N, Al-Talib T, Nelson S, et al. · J Dent Sci · 2021
- Final results of the multicenter, prospective Axium MicroFX for Endovascular Repair of IntraCranial Aneurysm Study (AMERICA).
Fargen KM, Blackburn S, Deshaies EM, et al. · J Neurointerv Surg · 2015Clinical Trial, Multicenter Study
- Identification of microbiological factors associated with periodontal health disparities.
Wang BY, Cao A, Ho MH, et al. · Front Cell Infect Microbiol · 2023Research Support, N.I.H., Extramural
- Early results of the Axium MicroFX for Endovascular Repair of IntraCranial Aneurysm (AMERICA) study: a multicenter prospective observational registry.
Fargen KM, Blackburn S, Carpenter JS, et al. · J Neurointerv Surg · 2014Multicenter Study, Observational Study
- In-vitro thrombogenicity assessment of polymer filament modified and native platinum embolic coils.
Girdhar G, Read M, Sohn J, et al. · J Neurol Sci · 2014
- In-vitro pliability assessment of embolization coils for intracranial aneurysm treatment.
Zhao R, Liu J, McComas S, et al. · J Neurol Sci · 2019
- Potential Microbiological Risk Factors Associated With Periodontitis and Periodontal Health Disparities.
Wang BY, Lu T, Cai Q, et al. · Front Cell Infect Microbiol · 2021Research Support, N.I.H., Extramural
- Spontaneous Cerebrospinal Fluid Rhinorrhea Secondary to Idiopathic Intracranial Hypertension.
Ali M, Elgassim MA, Faisal HM, et al. · Cureus · 2023Case Reports
- Development and integration of a clinical dashboard within a dental school setting.
Afshari FS, Yuan JC, Sukotjo C, et al. · J Dent Educ · 2024
Other devices of this type
Also filed under product code PMP.
- Proclaim DRG IPG (Model 3664)Abbott Medical · PMA 2023
- Proclaim Dorsal Root Ganglion (DRG) Neurostimulator SystemAbbott Medical · PMA 2026
- Dorsal Root Ganglion (DRG) Neurostimulation SystemAbbott Medical · PMA 2025
- SlimTip Dorsal Root Ganglion (DRG) Trial Lead KitAbbott Medical · PMA 2025
- Family of DRG IPGsAbbott Medical · PMA 2024
- NextGen DRG Lead Kit and AccessoriesAbbott Medical · PMA 2021
- Proclaim SCS Neurostimulator SystemAbbott Medical · PMA 2021
- PmpAbbott Medical · PMA 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.